Table 1. Incidence of patients with MALT-lymphoma between 1999 and 2017 in Korea.

Year	C88.4, No.	C88, No.	C88.4/C88, %	C88.4
				Crude incidence ratea			Age-standardized incidence ratea
				All	Male	Female	All	Male	Female
1999	93	95	97.9	0.20	0.19	0.20	0.20	0.21	0.20
2000	73	78	93.6	0.15	0.15	0.16	0.15	0.15	0.15
2001	86	99	86.9	0.18	0.15	0.21	0.17	0.16	0.20
2002	183	193	94.8	0.38	0.38	0.38	0.36	0.38	0.36
2003	326	336	97.0	0.67	0.64	0.71	0.63	0.63	0.64
2004	340	349	97.4	0.70	0.68	0.72	0.64	0.65	0.64
2005	441	450	98.0	0.91	0.79	1.03	0.82	0.74	0.91
2006	471	483	97.5	0.96	0.83	1.10	0.86	0.76	0.97
2007	456	475	96.0	0.93	0.85	1.01	0.81	0.77	0.86
2008	564	578	97.6	1.14	0.97	1.31	0.98	0.86	1.10
2009	719	734	98.0	1.45	1.35	1.55	1.21	1.16	1.27
2010	714	730	97.8	1.43	1.21	1.66	1.18	1.03	1.35
2011	806	827	97.5	1.61	1.31	1.91	1.30	1.07	1.53
2012	853	884	96.5	1.69	1.52	1.86	1.34	1.23	1.47
2013	896	918	97.6	1.77	1.56	1.98	1.35	1.22	1.48
2014	910	935	97.3	1.79	1.63	1.96	1.37	1.27	1.47
2015	917	943	97.2	1.80	1.71	1.89	1.36	1.32	1.40
2016	1,159	1,190	97.4	2.27	2.21	2.32	1.65	1.64	1.67
2017	1,121	1,147	97.7	2.19	2.11	2.27	1.57	1.53	1.61

MALT-lymphoma = extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

^aPer 100,000 person.